Zevra Therapeutics to Present at Canaccord Genuity's 44th Annual Growth Conference

Core Viewpoint - Zevra Therapeutics, Inc. will present at Canaccord Genuity's 44th Annual Growth Conference, highlighting its focus on rare disease therapeutics and commitment to developing transformational therapies for patients with limited treatment options [1]. Company Overview - Zevra Therapeutics is dedicated to creating therapies for rare diseases by combining science, data, and patient needs, aiming to provide life-changing therapeutics [3]. - The company employs unique, data-driven development and commercialization strategies to address complex drug development challenges [3]. Event Participation - Neil F. McFarlane, President and CEO of Zevra, will present at the conference on August 14, 2024, at 10:30 a.m. ET, with opportunities for one-on-one investor meetings available throughout the event [1]. - Live webcasts of the presentation can be accessed through the "Events & Presentations" section of Zevra's website [2].